COVID-19 Puts Hope on Hold for Rare Disease Patients
Medicare Rule Could Delay Migraine, Movement Disorder Treatment
How COVID-19 Could Change Clinical Trials
COVID-19 Ushers in New Normal for Cancer Trials
Will COVID-19 Boost Clinical Trials Awareness?
Cures 2.0 Takes Off
Prior Authorization’s Snowball Effect
New Paper Highlights Amyloidosis Patients’ Struggle for Access
Spike in Hepatitis C Signals Treatment Access Barriers
ICER Report Adds Insult to Injury for Cystic Fibrosis Patients
